Former FDA Commissioner or Wife Held Stock in FDA Regulated Area – NYT

Former FDA Commissioner or Wife Held Stock in FDA Regulated Area – NYT Thu, 27 Oct 2005 The mystery behind the resignation of Dr. Lester Crawford seems to be about failure to divest from financail holdings in companies regualted by the FDA. The New York Times cites Dr. Crawford’s statement…

Grassley Pushes FDA: Transparency, Accountability & Independence / Whistleblowers are essential Witnesses

Grassley Pushes FDA: Transparency, Accountability & Independence / Whistleblowers are essential Witnesses Wed, 8 Jun 2005 The FDA has once again demonstrated bad faith when it appointed an industry biased panel to monitor drug safety. The Washington Post reports that FDA safety officer Dr. David Graham, who blew the whistle…

Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones

Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones Mon, 25 Apr 2005 Mother Jones and The New York Times focus on the Vioxx fall out–a case that encapsulates the corrupt practices in drug research. Merck and FDA officials intervened to conceal the lethal cardiac effect of Vioxx. Mother…

AHRP Ethical and Scientific Objections to FDA’s Proposed Licensure of Anthrax Vaccine

When a federal judge ruled the vaccine to be an "investigational drug and a drug being used for an unapproved purpose" on December 22, 2003, FDA hurriedly issued a Final Rule for anthrax vaccine. The agency submitted its Final Rule just eight days after a federal court injunction, having failed to do so for 19 years. In a January 7, 2004 court hearing the same judge called FDA’s actions "highly suspicious." On October 27, 2004 FDA’s arbitrary and capricious promulgation of this Final Rule resulted in a permanent injunction, remanding the license to your agency to complete according to the law. The injunction also halted what the judge called DoD’s "illegal" mandatory anthrax vaccination program.

FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT

FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT Thu, 17 Feb 200 A three day public advisory panel hearing which is overflowing with attendees from around the world, is an investigation of the conduct of pharmaceutical company giants and the FDA. The hearing began…

Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement

Complaint to FDA: Pfizer Failed to Disclose Zoloft Suicide Risk in NYT Adverstisement Mon, 1 Nov 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 142 West End Ave. Suite 28P Fax: 212-595-9086   New York, NY 10023     www.ahrp.org   November 1, 2004 Thomas W. Abrams Director Office…